🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Laith Abushahin

ORCID: 0000-0001-5155-1185

Also affiliated with Baylor University Medical Center, The Ohio State University Wexner Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Altered Gemcitabine and Nab-paclitaxel Scheduling Improves Therapeutic Efficacy Compared with Standard Concurrent Treatment in Preclinical Models of Pancreatic Cancer”.

Altered Gemcitabine and Nab-paclitaxel Scheduling Improves Therapeutic Efficacy Compared with Standard Concurrent Treatment in Preclinical Models of Pancreatic Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1422

N/A

0DataRank · unranked

16 citations

Ryan Robb, Ahmad Hegazi, Laith Abushahin, Linlin Yang, Duan-Liang Shyu +7 more

Neoadjuvant‐modified FOLFIRINOX vs nab‐paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgical resection

Cancer Medicine(2020)10.1002/cam4.3075

N/A

0DataRank · unranked

38 citations

Dhivya Prabhakar, Vedat Yildiz, Jordan M. Cloyd, Mary Dillhoff, Laith Abushahin +7 more

Stage I Squamous Cell Carcinoma of the Anus: Is Radiation Therapy Alone Sufficient Treatment?

Cancers(2020)10.3390/cancers12113248

N/A

0DataRank · unranked

5 citations

Ansel P. Nalin, Dayssy A. Diaz, Andrea Arnett, Laith Abushahin, Syed Husain +4 more

Tumor treating fields: An emerging treatment modality for thoracic and abdominal cavity cancers

Translational Oncology(2021)10.1016/j.tranon.2021.101296

N/A

0DataRank · unranked

18 citations

Jonathan W. Song, Laith Abushahin, Travis H. Jones

Development of a MicroRNA Signature Predictive of Recurrence and Survival in Pancreatic Ductal Adenocarcinoma

Cancers(2021)10.3390/cancers13205168

N/A

0DataRank · unranked

2 citations

Amy Webb, Kenneth W. Merrell, Eugene J. Koay, Adam R. Wolfe, Lizhi Zhang +11 more

Phase Ib study of anetumab ravtansive in combination with immunotherapy or immunotherapy plus chemotherapy in mesothelin-enriched advanced pancreatic adenocarcinoma: NCI10208.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4136

N/A

0DataRank · unranked

12 citations

Anup Kasi, Laith Abushahin, Dana B. Cardin, Heinz‐Josef Lenz, Farshid Dayyani +15 more